SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-23-113852
Filing Date
2023-11-02
Accepted
2023-11-02 17:00:19
Documents
12
Period of Report
2023-11-02
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2329706d1_8ka.htm   iXBRL 8-K/A 27399
  Complete submission text file 0001104659-23-113852.txt   201917

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nvax-20231102.xsd EX-101.SCH 3012
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20231102_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20231102_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2329706d1_8ka_htm.xml XML 4031
Mailing Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-26770 | Film No.: 231373395
SIC: 2836 Biological Products, (No Diagnostic Substances)